Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Study Highlights Proton Pump Inhibitor Use in Infants

The findings of a new study are raising concerns about the frequent use of heartburn medications, including proton pump inhibitors, in infants. The authors of the paper, which appeared last month in The Journal of Pediatrics, have called for additional … Continue reading

Risperdal Lawsuit Judge Ups $70 Million Gynecomastia Verdict

A Risperdal gynecomastia plaintiff who had already been granted $70 million in compensatory damages by the Pennsylvania jurying hearing his case just saw that figure increase by more than $6 million. According to a report from Law360.com, the judge overseeing … Continue reading

Levaquin Attorneys File 13 Peripheral Neuropathy Lawsuits, More Expected

The nationwide law firm of Bernstein Liebhard LLP recently filed 13 Levaquin lawsuits in New Jersey federal court on behalf of individuals who allegedly developed peripheral neuropathy due to their use of the popular antibiotic. According to a report from … Continue reading

Three Cook IVC Lawsuits Chosen for First Federal Trials

The federal court overseeing pretrial proceedings for hundreds of Cook IVC filter lawsuits has chosen three cases for the proceeding’s first bellwether trials. Those trials will be conducted in 2017, and could provide clues as to how juries might rule … Continue reading

JPML Schedules Oral Arguments for Talc Powder Lawsuits, Taxotere Hair Loss Claims And More

The U.S. Judicial Panel on Multidistrict Litigation is schedule d to convene a Hearing Session next month in Washington, D.C. At that time, the Panel will hear Oral Arguments on motions to centralize all federally-filed Taxotere hair loss claims, as … Continue reading

FDA Proposes Changes to 510(K) Clearance Program Guidance

The U.S. Food & Drug Administration (FDA) has proposed new guidance that  could significantly change certain aspects of the agency’s 510(K) clearance program. Among other things, the new draft guidance would require device manufacturers to determine whether alterations to a … Continue reading

Levaquin Lawsuit Court Delays Decision on California Remand Motion

The federal court overseeing hundreds of peripheral neuropathy lawsuits involving Levaquin and other fluoroquinolone antibiotics has declined to rule on a remand motion filed by a group of California plaintiffs. According to an August 5th Order issued in the U.S. … Continue reading

New E-Cig Regulations Go Into Effect Today

Federal regulations pertaining to  e-cigarettes and other tobacco products go into effect today. Among other things, the  new rules should make it more difficult for minors to vape. The U.S. Food & Drug Administration (FDA) regulations cover electronic cigarettes, as … Continue reading

Talcum Powder Lawsuit Defendants Support MDL, Propose Alternate Venues

Johnson & Johnson and other talcum powder lawsuit plaintiffs have voiced their support for the centralization of all federally-filed ovarian cancer claims involving Baby Powder and Shower-to-Shower talc-based products. However, responses filed with the U.S. Judicial Panel on Multidistrict Litigation … Continue reading

Calcium Supplements May Protect Nexium Users from B12 Deficiency

B12 deficiency can occur among long-term users of Nexium and other acid-blocking medications. Now a new study suggests that calcium supplements could reduce the risk for this serious complication. Proton Pump Inhibitors and B12 Deficiency Nexium and other proton pump … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content